Literature DB >> 14415902

The properdin system and immunity. X. Characterization of partially purified human properdin.

I H LEPOW, L PILLEMER, M D SCHOENBERG, E W TODD, R J WEDGWOOD.   

Abstract

Entities:  

Keywords:  PROPERDIN/chemistry

Mesh：

Substances：

Year:  1959        PMID： 14415902

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  10 in total

1.  Serum and tissue inhibitors of virus.

Authors:  H S GINSBERG
Journal:  Bacteriol Rev       Date:  1960-03

Review 2.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

3.  Some serological characteristics of normal incomplete cold antibody.

Authors:  M Adinolfi
Journal:  Immunology       Date:  1965-07       Impact factor: 7.397

4.  Resolution and analysis of 'native' and 'activated' properdin.

Authors:  T C Farries; J T Finch; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

5.  Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.

Authors:  M Takahashi; S Takahashi; V Brade; V Nussenzweig
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

Review 6.  Discrimination between host and pathogens by the complement system.

Authors:  Michael K Pangburn; Viviana P Ferreira; Claudio Cortes
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

Review 7.  Properdin: approaching four decades of research.

Authors:  K K Maves; J M Weiler
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

8.  Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement.

Authors:  J Chapitis; I H Lepow
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

Review 9.  How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.

Authors:  R Gasparini; D Panatto; N L Bragazzi; P L Lai; A Bechini; M Levi; P Durando; D Amicizia
Journal:  J Immunol Res       Date:  2015-08-17       Impact factor: 4.818

10.  The role of properdin in the alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.